Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06423664 · ClinicalTrials.gov registry record · NA
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
A NA study of Developmental Delay, sponsored by IDeA States Pediatric Clinical Trials Network.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 3
- Study locations
NCT06423664: Recruiting NA study of Developmental Delay, sponsored by IDeA States Pediatric Clinical Trials Network.
NCT06423664 is a NA study of Developmental Delay that is actively recruiting participants, run by IDeA States Pediatric Clinical Trials Network. The registered enrollment target is 20 participants, below the 295-participant average among 10 other Developmental Delay trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06423664, a NA study of Developmental Delay, is actively recruiting participants, sponsored by IDeA States Pediatric Clinical Trials Network.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 3
- Study locations
Study Summary
The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will evaluate feasibility endpoints rather than clinical outcomes. The study duration is 22 months, including study start-up, enrollment and intervention, and data analysis and manuscript preparation.
Primary Outcome
Whether a potential participant approached for study participation will eventually be consented and determined to be eligible for study participation.
Conditions Studied
Interventions
- BEHAVIORAL Play and Learn Strategies (PALS) Program
Study Locations (3)
New Mexico
- University of New Mexico Health Sciences Center - Albuquerque
South Dakota
- Avera Research Institute - Sioux Falls
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What NCT06423664 shows while recruiting
NCT06423664 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 295-participant average among 10 other Developmental Delay trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Developmental Delay appearing as the primary indexed condition, and to 1 intervention - of which Play and Learn Strategies (PALS) Program is the first listed.
NCT06423664 reports a single indexed study location in New Mexico, South Dakota, Vermont.
Frequently Asked Questions
What is clinical trial NCT06423664 about?
NCT06423664 is a clinical study titled "Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure". The INTACT trial is a multisite pilot feasibility study aimed at testing the effectiveness of the INTACT Intervention program in improving neurodevelopmental outcomes in infants prenatally exposed to cannabinoids. The trial will enroll 20 birthing parent/infant dyads across three sites and will eval...
What is the current status of trial NCT06423664?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-06. Estimated completion is 2026-08-31.
What conditions does trial NCT06423664 study?
This clinical trial studies the following conditions: Developmental Delay.
What interventions are being tested in trial NCT06423664?
The interventions under investigation include: Play and Learn Strategies (PALS) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT06423664?
This trial is sponsored by IDeA States Pediatric Clinical Trials Network, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06423664 being conducted?
This trial has 3 study locations across New Mexico, South Dakota, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Developmental Delay
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06423664's enrollment target sits among peer trials
20 10th of 10 higher than 1 of 10 other Developmental Delay trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Developmental Delay trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
School-based Support for Pre-school Aged Children With Developmental Disabilities and Delays
RECRUITING · NA
-
Problem Behavior Assessment and Intervention in IDEA Part C Services
RECRUITING · NA
-
Exploratory Trial of a Pediatric Web-Based Care Planning Guide
ACTIVE NOT RECRUITING · NA
-
Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism
COMPLETED · NA
-
The CHICA Developmental Screening Study
COMPLETED · NA
-
Longitudinal Study of Neurogenetic Disorders
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI